Simplex Trading, LLC Omega Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,509 shares of OMGA stock, worth $1,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,509

Holding current value

$1,267

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.22 - $2.25 $1,840 - $3,395	1,509 New	1,509 $1,000
Q1 2024 Apr 25, 2024	SELL	$2.73 - $5.32 $4,548 - $8,863	-1,666 Reduced 67.94%	786 $2,000
Q4 2023 Feb 02, 2024	SELL	$1.35 - $3.21 $8,996 - $21,391	-6,664 Reduced 73.1%	2,452 $7,000
Q3 2023 Nov 01, 2023	BUY	$2.15 - $5.68 $14,684 - $38,794	6,830 Added 298.78%	9,116 $19,000
Q2 2023 Aug 04, 2023	BUY	$5.6 - $9.66 $12,801 - $22,082	2,286 New	2,286 $12,000
Q4 2022 Feb 02, 2023	SELL	$4.22 - $7.05 $8,651 - $14,452	-2,050 Reduced 15.8%	10,921 $62,000
Q3 2022 Nov 04, 2022	BUY	$3.63 - $6.65 $18,425 - $33,755	5,076 Added 64.29%	12,971 $70,000
Q2 2022 Aug 03, 2022	BUY	$2.01 - $7.19 $15,864 - $56,750	7,893 Added 394650.0%	7,895 $30,000
Q1 2022 May 02, 2022	BUY	$6.24 - $14.04 $12 - $28	2 New	2 $0

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

Flagship Pioneering Inc. Cambridge, MA

29.2M
Shares

$24.5 Million
6.05% of portfolio
Harbourvest Partners LLC Boston, MA

3.51M
Shares

$2.95 Million
2.28% of portfolio
State Of Wisconsin Investment Board Madison, WI

1.86M
Shares

$1.56 Million
0.01% of portfolio
Siren, L.L.C. New York, NY

1.32M
Shares

$1.11 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.11M
Shares

$936,374
0.0% of portfolio

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $40.2M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account